CHEMBL4293307
SMILES | COc1ccc(N(CCCCN2CCC(O)(c3ccc(Cl)c(C(F)(F)F)c3)CC2)c2ccc(OC)cc2)cc1 |
InChIKey | DYLSSJRMONSQGQ-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 5 |
Hydrogen bond donors | 1 |
Rotatable bonds | 10 |
Molecular weight (Da) | 562.2 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT5A | 5HT5A | Human | 5-Hydroxytryptamine | A | pKi | 5.3 | 5.3 | 5.3 | ChEMBL |
μ | OPRM | Human | Opioid | A | pKi | 5.08 | 5.08 | 5.08 | ChEMBL |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 5.0 | 5.0 | 5.0 | ChEMBL |
5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 5.0 | 5.0 | 5.0 | ChEMBL |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.05 | 6.05 | 6.05 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 6.14 | 6.14 | 6.14 | ChEMBL |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.13 | 6.13 | 6.13 | ChEMBL |
5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 5.85 | 5.85 | 5.85 | ChEMBL |
5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pKi | 6.02 | 6.02 | 6.02 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKi | 5.0 | 5.0 | 5.0 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 6.38 | 6.38 | 6.38 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pKi | 6.36 | 6.36 | 6.36 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pKi | 6.34 | 6.34 | 6.34 | ChEMBL |
D5 | DRD5 | Human | Dopamine | A | pKi | 6.21 | 6.21 | 6.21 | ChEMBL |
H1 | HRH1 | Human | Histamine | A | pKi | 5.15 | 5.15 | 5.15 | ChEMBL |
δ | OPRD | Human | Opioid | A | pKi | 5.0 | 5.0 | 5.0 | ChEMBL |
κ | OPRK | Human | Opioid | A | pKi | 5.0 | 5.0 | 5.0 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |